» Articles » PMID: 37110691

In Vivo Neuropharmacological Effects of Neophytadiene

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Apr 28
PMID 37110691
Authors
Affiliations
Soon will be listed here.
Abstract

Neophytadiene (NPT) is a diterpene found in the methanolic extracts of and , plants reported with anxiolytic-like activity, sedative properties, and antidepressant-like actions; however, the contribution of neophytadiene to these effects is unknown. This study determined the neuropharmacological (anxiolytic-like, antidepressant-like, anticonvulsant, and sedative) effects of neophytadiene (0.1-10 mg/kg p.o.) and determined the mechanisms of action involved in the neuropharmacological actions using inhibitors such as flumazenil and analyzing the possible interaction of neophytadiene with GABA receptors using a molecular docking study. The behavioral tests were evaluated using the light-dark box, elevated plus-maze, open field, hole-board, convulsion, tail suspension, pentobarbital-induced sleeping, and rotarod. The results showed that neophytadiene exhibited anxiolytic-like activity only to the high dose (10 mg/kg) in the elevated plus-maze and hole-board tests, and anticonvulsant actions in the 4-aminopyridine and pentylenetetrazole-induced seizures test. The anxiolytic-like and anticonvulsant effects of neophytadiene were abolished with the pre-treatment with 2 mg/kg flumazenil. In addition, neophytadiene showed low antidepressant effects (about 3-fold lower) compared to fluoxetine. On other hand, neophytadiene had no sedative or locomotor effects. In conclusion, neophytadiene exerts anxiolytic-like and anticonvulsant activities with the probable participation of the GABAergic system.

Citing Articles

Impact of Drying Methods on Bioactive Compounds and Antioxidant Properties of .

Manalu L, Adinegoro H, Yustiningsih N, Astuti , Luthfiyanti R, Maisaroh Scientifica (Cairo). 2025; 2025:7146758.

PMID: 40017992 PMC: 11867725. DOI: 10.1155/sci5/7146758.


Comprehensive metabolite profiling and evaluation of anti-nociceptive and anti-inflammatory potencies of (Wurmb.) leaves: Experimental and in-silico approaches.

Islam F, Aktaruzzaman M, Islam M, Rodru F, Yesmine S Heliyon. 2025; 11(3):e42074.

PMID: 39975840 PMC: 11835622. DOI: 10.1016/j.heliyon.2025.e42074.


Biological Activities and Phytochemical Screening of Extracts with In Silico Approaches.

Younes K, Abouzied A, Alqarni S, Elkashlan A, Hussein W, Alhathal R Int J Mol Sci. 2025; 26(3).

PMID: 39940708 PMC: 11817169. DOI: 10.3390/ijms26030939.


Integrative transcriptome and metabolome analysis reveals candidate genes related to terpene synthesis in Chrysanthemum × morifolium.

Yu K, Hu Y, Ye J, Ni R, Yang R, Chen F BMC Plant Biol. 2025; 25(1):173.

PMID: 39930381 PMC: 11808959. DOI: 10.1186/s12870-025-06163-z.


Exploring the anticancer potential of Hewittia malabarica through phytochemical analysis and molecular docking study.

Thozhukkad Moosaripparambil S, Vadakkadath Meethal K Sci Rep. 2025; 15(1):4088.

PMID: 39901023 PMC: 11791203. DOI: 10.1038/s41598-025-88572-6.


References
1.
Rauf A, Rahman M . Potential therapeutics against neurological disorders: Natural products-based drugs. Front Pharmacol. 2022; 13:950457. PMC: 9437920. DOI: 10.3389/fphar.2022.950457. View

2.
Bourin M, Hascoet M . The mouse light/dark box test. Eur J Pharmacol. 2003; 463(1-3):55-65. DOI: 10.1016/s0014-2999(03)01274-3. View

3.
Alonso-Castro A, Alba-Betancourt C, Rocha-Gonzalez E, Ruiz-Arredondo A, Zapata-Morales J, Gasca-Martinez D . Neuropharmacological effects of d-pinitol and its possible mechanisms of action. J Food Biochem. 2019; 43(12):e13070. DOI: 10.1111/jfbc.13070. View

4.
Alonso-Castro A, Gasca-Martinez D, Cortez-Mendoza L, Alba-Betancourt C, Ruiz-Padilla A, Zapata-Morales J . Evaluation of the neuropharmacological effects of Gardenin A in mice. Drug Dev Res. 2020; 81(5):600-608. DOI: 10.1002/ddr.21659. View

5.
Feigin V . The Evolution of Neuroepidemiology: Marking the 40-Year Anniversary of Publishing Studies on Epidemiology of Neurological Disorders. Neuroepidemiology. 2021; 56(1):2-3. DOI: 10.1159/000521586. View